Journal of Clinical Immunology

, Volume 38, Issue 1, pp 28–34 | Cite as

Autoimmune Cytopenias and Associated Conditions in CVID: a Report From the USIDNET Registry

  • Elizabeth J. Feuille
  • Niloofar Anooshiravani
  • Kathleen E. Sullivan
  • Ramsay L. Fuleihan
  • Charlotte Cunningham-Rundles
Original Article



Autoimmune cytopenia is frequently a presenting manifestation of common variable immune deficiency (CVID). Studies characterizing the CVID phenotype associated with autoimmune cytopenias have mostly been limited to large referral centers. Here, we report prevalence of autoimmune cytopenias in CVID from the USIDNET Registry and compare the demographics and clinical features of patients with and without this complication.


Investigators obtained demographic, laboratory, and clinical data on CVID patients within the USIDNET Registry. Patients were considered to have autoimmune cytopenia if they had a diagnosis of hemolytic anemia, immune thrombocytopenia (ITP), or autoimmune neutropenia. Baseline characteristics and associated complications of those with autoimmune cytopenia (+AC) and those without (−AC) were compared.


Of 990 CVID patients included in the analysis, 10.2% (N = 101) had a diagnosis consistent with autoimmune cytopenia: ITP was diagnosed in 7.4% (N = 73), hemolytic anemia in 4.5% (N = 45), and autoimmune neutropenia in 1% (N = 10). Age at diagnosis, gender, and baseline Ig values did not differ between the +AC and –AC groups. The +AC group was significantly more likely to have one or more other CVID-associated non-infectious complications (OR = 2.9; 95%-CI: 1.9–4.6, P < 0.001), including lymphoproliferation, granulomatous disease, lymphomas, hepatic disease, interstitial lung diseases, enteropathy, and organ-specific autoimmunity.


Autoimmune cytopenias are a common manifestation in CVID and are likely to be associated with other non-infectious CVID-related conditions. In light of prior studies showing increased morbidity and mortality in CVID patients with such complications, a diagnosis of autoimmune cytopenia may have prognostic significance in CVID.


Common variable immunodeficiency autoimmunity immune thrombocytopenia Evans syndrome neutropenia hemolytic anemia 



We acknowledge Marla Goldsmith (USIDNET Registry Manager) and Tara Caulder (USIDNET Project Director) for their expertise in data management and assistance in obtaining and analyzing registry data. We acknowledge the following individual physicians who contributed 10 or more patients to the CVID cohort analyzed: Daniel Suez, MD; Patricia Lugar, MD; John Routes, MD; Francisco Bonilla, MD PhD; Avni Joshi, MD; Ralph Shapiro, MD; Zuhair Ballas, MD; Gary Kleiner, MD PhD; Elizabeth Secord, MD; Elie Haddad, MD PhD; Robert Hostoffer, DO; Rebecca Buckley, MD; James Crowley, MD; Jolan Walter, MD PhD; Warren Strober MD; Alexander Lawton, MD; Nabih Abdou, MD; Hans Ochs, MD; Leonard Calabrese, DO; Susan Schuval, MD; Niraj Patel, MD; Wesley Burks, MD; Mark Stein, MD; and Jennifer Puck, MD. We acknowledge Adam Thomas Grealish for his contributions to data analysis.

Authors Contributions

Dr. Feuille assisted in study design, conducted statistical analysis on survey responses, drafted the initial manuscript, and approved the final manuscript as submitted.

Dr. Anooshiravani assisted with study design, analysis and interpretation of data, reviewed and revised the manuscript, and approved the final manuscript as submitted.

Dr. Fuleihan assisted with study design, analysis and interpretation of data, reviewed and revised the manuscript, and approved the final manuscript as submitted.

Dr. Cunningham-Rundles conceptualized the study, assisted in analysis and interpretation of data, drafted the initial manuscript, and approved the final manuscript as submitted.

Compliance with Ethical Standards

Conflicts of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4:38–59.CrossRefPubMedGoogle Scholar
  2. 2.
    Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35:696–726.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277–86.CrossRefPubMedGoogle Scholar
  4. 4.
    Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650–7.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol. 2013;174:203–11.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Gathmann B, Mahlaoui N, Ceredih L, Gerard E, Oksenhendler K, Warnatz I, et al. European Society for Immunodeficiencies Registry Working. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:116–26.CrossRefPubMedGoogle Scholar
  7. 7.
    Marschall K, Hoernes M, Bitzenhofer-Gruber M, Jandus P, Duppenthaler A, Wuillemin WA, et al. The Swiss National Registry for primary immunodeficiencies: report on the first 6 years’ activity from 2008 to 2014. Clin Exp Immunol. 2015;182:45–50.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Boileau J, Mouillot G, Gerard L, Carmagnat M, Rabian C, Oksenhendler E, et al. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimmun. 2011;36:25–32.CrossRefPubMedGoogle Scholar
  9. 9.
    Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun. 2005;25:57–62.CrossRefPubMedGoogle Scholar
  10. 10.
    Michel M, Chanet V, Galicier L, Ruivard M, Levy Y, Hermine O, et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore). 2004;83:254–63.CrossRefGoogle Scholar
  11. 11.
    Maglione PJ, Overbey JR, Cunningham-Rundles C. Progression of common variable immunodeficiency interstitial lung disease accompanies distinct pulmonary and laboratory findings. J Allergy Clin Immunol Pract. 2015;3:941–50.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Mannina A, Chung JH, Swigris JJ, Solomon JJ, Huie TJ, Yunt ZX, et al. Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease. Ann Am Thorac Soc. 2016;13:1042–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Ward C, Lucas M, Piris J, Collier J, Chapel H. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol. 2008;153:331–7.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Terrell DR, Beebe LA, Neas BR, Vesely SK, Segal JB, George JN. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012;87:848–52.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29:1–9.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Aladjidi N, Jutand MA, Beaubois C, Fernandes H, Jeanpetit J, Coureau G, Gilleron V, Kostrzewa A, Lauroua P, Jeanne M, Thiebaut R, Leblanc T, Leverger G, Perel Y. Reliable assessment of the incidence of childhood autoimmune hemolytic anemia. Pediatr Blood Cancer. 2017.Google Scholar
  17. 17.
    Lyall EG, Lucas GF, Eden OB. Autoimmune neutropenia of infancy. J Clin Pathol. 1992;45:431–4.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Fischer A, Provot J, Jais JP, Alcais A, Mahlaoui N, C.F.P.I.D.s.g. members of the, autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2017.Google Scholar
  19. 19.
    Ardeniz O, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol. 2009;133:198–207.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Morimoto Y, Routes JM. Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep. 2005;5:370–5.CrossRefPubMedGoogle Scholar
  21. 21.
    Maglione PJ, Overbey JR, Radigan L, Bagiella E, Cunningham-Rundles C. Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations. Ann Allergy Asthma Immunol. 2014;113:452–9.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190–207.CrossRefPubMedGoogle Scholar
  23. 23.
    Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–86.CrossRefPubMedGoogle Scholar
  24. 24.
    Lucas G, Rogers S, de Haas M, Porcelijn L, Bux J. Report on the fourth international granulocyte immunology workshop: progress toward quality assessment. Transfusion. 2002;42:462–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Kyono W, Coates TD. A practical approach to neutrophil disorders. Pediatr Clin N Am. 2002;49:929–71. viiiCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Weill Cornell Medical CollegeNew YorkUSA
  2. 2.Children’s Hospital of PhiladelphiaPhiladelphiaUSA
  3. 3.Children’s Memorial HospitalChicagoUSA

Personalised recommendations